Militia Capital Management LLC Purchases Shares of 20,700 Align Technology, Inc. $ALGN

Militia Capital Management LLC acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) in the 1st quarter, Holdings Channel reports. The institutional investor acquired 20,700 shares of the medical equipment provider’s stock, valued at approximately $3,549,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Capital International Investors grew its holdings in shares of Align Technology by 52.2% in the 4th quarter. Capital International Investors now owns 4,643,221 shares of the medical equipment provider’s stock worth $725,039,000 after purchasing an additional 1,592,848 shares during the last quarter. Ruane Cunniff & Goldfarb L.P. bought a new position in Align Technology during the 4th quarter valued at about $190,899,000. Norges Bank bought a new position in Align Technology during the 4th quarter valued at about $155,556,000. Assenagon Asset Management S.A. boosted its position in Align Technology by 413.0% in the first quarter. Assenagon Asset Management S.A. now owns 989,388 shares of the medical equipment provider’s stock valued at $169,611,000 after buying an additional 796,529 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in Align Technology by 247.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,005,413 shares of the medical equipment provider’s stock valued at $156,995,000 after buying an additional 715,919 shares in the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.

More Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
• Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
• Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
• Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
• Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

Align Technology Stock Performance

NASDAQ ALGN opened at $169.16 on Monday. The stock has a fifty day moving average of $174.55 and a 200-day moving average of $175.23. The stock has a market capitalization of $12.12 billion, a P/E ratio of 29.42, a price-to-earnings-growth ratio of 1.78 and a beta of 1.65. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $200.43.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, topping analysts’ consensus estimates of $2.62 by $0.02. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Align Technology had a return on equity of 15.86% and a net margin of 9.99%.The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.49 earnings per share. Equities research analysts forecast that Align Technology, Inc. will post 9.48 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has approved a stock repurchase plan on Wednesday, April 29th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to reacquire up to 1.6% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

Several analysts have recently weighed in on ALGN shares. Leerink Partners raised their price objective on shares of Align Technology from $225.00 to $230.00 in a report on Thursday, April 30th. Wall Street Zen lowered Align Technology from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Zacks Research downgraded Align Technology from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 16th. Finally, Citigroup started coverage on Align Technology in a research note on Wednesday, April 15th. They issued a “buy” rating and a $240.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $206.36.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.